Serveur d'exploration SRAS - Analysis (2020)

Index « Auteurs » - entrée « Zhengli Shi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Zhenghong Peng < Zhengli Shi < Zhengli Wang  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000316 (2020) Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
000400 (2020) Xiaolong Tian [République populaire de Chine] ; Cheng Li [République populaire de Chine] ; Ailing Huang [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Sicong Lu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Zhenlin Yang [République populaire de Chine] ; Yanling Wu [République populaire de Chine] ; Tianlei Ying [République populaire de Chine]Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody.
000473 (2020) Yushun Wan [États-Unis] ; Jian Shang [États-Unis] ; Shihui Sun [République populaire de Chine] ; Wanbo Tai [États-Unis] ; Jing Chen [République populaire de Chine] ; Qibin Geng [États-Unis] ; Lei He [République populaire de Chine] ; Yuehong Chen [République populaire de Chine] ; Jianming Wu [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] ; Lanying Du [États-Unis] ; Fang Li [États-Unis]Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
000541 (2020) Shuai Xia [République populaire de Chine] ; Meiqin Liu [République populaire de Chine] ; Chao Wang [République populaire de Chine] ; Wei Xu [République populaire de Chine] ; Qiaoshuai Lan [République populaire de Chine] ; Siliang Feng [République populaire de Chine] ; Feifei Qi [République populaire de Chine] ; Linlin Bao [République populaire de Chine] ; Lanying Du [États-Unis] ; Shuwen Liu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Fei Sun [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Shibo Jiang [République populaire de Chine, États-Unis] ; Lu Lu [République populaire de Chine]Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
2Amino Acid Sequence
2Animals
2Antibodies, Monoclonal (immunology)
2Antibodies, Viral (immunology)
2Betacoronavirus (drug effects)
2Chlorocebus aethiops
2Spike Glycoprotein, Coronavirus (immunology)
2Vero Cells
1Adenosine Monophosphate (analogs & derivatives)
1Adenosine Monophosphate (pharmacology)
1Adenosine Monophosphate (therapeutic use)
1Administration, Intranasal
1Alanine (analogs & derivatives)
1Alanine (pharmacology)
1Alanine (therapeutic use)
1Antibodies, Monoclonal (metabolism)
1Antibodies, Neutralizing (immunology)
1Antibodies, Neutralizing (metabolism)
1Antibodies, Viral (metabolism)
1Antibody-Dependent Enhancement
1Antimalarials (pharmacology)
1Antimalarials (therapeutic use)
1Antiviral Agents (pharmacology)
1Antiviral Agents (therapeutic use)
1Betacoronavirus (immunology)
1Betacoronavirus (pathogenicity)
1Betacoronavirus (physiology)
1Biological Assay
1Cell Fusion
1Cell Line
1Chloroquine (pharmacology)
1Chloroquine (therapeutic use)
1Coronavirus Infections
1Coronavirus Infections (drug therapy)
1Coronavirus Infections (prevention & control)
1Cross Reactions
1Dipeptidyl Peptidase 4 (metabolism)
1Drug Discovery
1Drug Evaluation, Preclinical
1HEK293 Cells
1Immunoglobulin Fab Fragments (immunology)
1Immunoglobulin Fab Fragments (metabolism)
1Lipopeptides (pharmacology)
1Membrane Fusion
1Mice
1Middle East Respiratory Syndrome Coronavirus (drug effects)
1Middle East Respiratory Syndrome Coronavirus (immunology)
1Middle East Respiratory Syndrome Coronavirus (pathogenicity)
1Middle East Respiratory Syndrome Coronavirus (physiology)
1Pandemics (prevention & control)
1Peptide Hydrolases (metabolism)
1Pneumonia, Viral
1Pneumonia, Viral (drug therapy)
1Pneumonia, Viral (prevention & control)
1Proprotein Convertases (antagonists & inhibitors)
1Proprotein Convertases (metabolism)
1Protein Conformation
1Protein Domains
1Protein Interaction Domains and Motifs
1Protein Multimerization
1Protein Structure, Secondary
1Protein Structure, Tertiary
1Receptors, Fc (metabolism)
1Receptors, IgG (immunology)
1Receptors, IgG (metabolism)
1Receptors, Virus (metabolism)
1SARS Virus
1SARS Virus (drug effects)
1SARS Virus (immunology)
1Sequence Alignment
1Sincalide
1Spike Glycoprotein, Coronavirus (antagonists & inhibitors)
1Spike Glycoprotein, Coronavirus (chemistry)
1Spike Glycoprotein, Coronavirus (metabolism)
1Structure-Activity Relationship
1Trypsin (metabolism)
1Virus Internalization

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i -k "Zhengli Shi" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Author.i  \
                -Sk "Zhengli Shi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Zhengli Shi
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021